Article: Biovest Becomes Charter Member of the Joint U.S.-Norway Cancer Research Program.

HEALTH AND BEAUTY CLOSE-UP-8 August 2008-Biovest Becomes Charter Member of the Joint U.S.-Norway Cancer Research Program(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Biovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, announced that Biovest has been designated one of the charter members of the Joint U.S.-Norway Cancer Research Program, a collaboration among leading pharmaceutical and biotechnology companies and research organizations with the vision of transforming world-class cancer diagnostics and treatments to improve and extend the lives of cancer patients.

The Joint U.S.-Norway Cancer Research Program will focus ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!